📋 Tender Overview
Consortium For Developing Regulatory Capacity For Clinical Trials Using Gene Therapy Products And Strengthening Pharmacovigilance In The Conduct Of Clinical Trials In East Africa
Gene Therapy Products In Clinical Trials In Africagene Therapy Shows Promise In Treating Chronic Conditions Like Hiv And Sickle-Cell Anaemia And Has The Potential To Reduce The Disease Burden In Sub-Saharan Africa. Uganda And Tanzania Are Pioneers In Clinical Trials For Gene Therapy Products. However, No Regulatory Frameworks For These Trials Exist. The Eu-Funded Capacity 2023 Project Aims To Strengthen Pharmacovigilance In Clinical Trials To Ensure Drug Safety For The Targeted Patient Population. It Will Address Challenges Such As Limited Access To Diagnostic Tools And Improve Investigator Awareness Of Their Responsibility To Monitor Adverse Events. The Project Aims To Accelerate Research And Access To Medical Technologies By Creating A Safe Environment For The Conduct Of Clinical Trials.
Funded Under
Health
Total Cost
€ 999 315,35
Eu Contribution
€ 999 315,35
Coordinated By
Universidade De Coimbra
Portugal
Start Date
1 April 2024
End Date
31 March 2027
